Literature DB >> 22855408

New directions for therapeutics in ADHD.

Julie B Schweitzer1, Keith McBurnett.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22855408      PMCID： PMC3441924          DOI： 10.1007/s13311-012-0137-6

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN： 1878-7479            Impact factor:   7.620


× No keyword cloud information.
  15 in total

Review 1.  What do we really know about ADHD in college students?

Authors:  Andrea L Green; David L Rabiner
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

Review 2.  ADHD treatments, sleep, and sleep problems: complex associations.

Authors:  Mark A Stein; Margaret Weiss; Laura Hlavaty
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

Review 3.  Clinical utility of EEG in attention-deficit/hyperactivity disorder: a research update.

Authors:  Sandra K Loo; Scott Makeig
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

Review 4.  The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review.

Authors:  Erik G Willcutt
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

Review 5.  Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

Authors:  Michael J Minzenberg
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

Review 6.  Psychological heterogeneity in AD/HD--a dual pathway model of behaviour and cognition.

Authors:  Edmund J S Sonuga-Barke
Journal:  Behav Brain Res       Date:  2002-03-10       Impact factor: 3.332

Review 7.  Preventive interventions for ADHD: a neurodevelopmental perspective.

Authors:  Jeffrey M Halperin; Anne-Claude V Bédard; Jocelyn T Curchack-Lichtin
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

Review 8.  Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder.

Authors:  Naomi Ornstein Davis; Scott H Kollins
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

Review 9.  Developmental phenotypes and causal pathways in attention deficit/hyperactivity disorder: potential targets for early intervention?

Authors:  Edmund J S Sonuga-Barke; Jeffrey M Halperin
Journal:  J Child Psychol Psychiatry       Date:  2009-12-08       Impact factor: 8.982

Review 10.  Reinforcement, dopamine and rodent models in drug development for ADHD.

Authors:  Gail Tripp; Jeff Wickens
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.